Cargando…

Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study

To investigate the prevalence of, and risk factors for, cervical infection with human papillomavirus (HPV) in Shenyang City, People's Republic of China, we interviewed and obtained cervical cell samples from 685 women aged 15–59 years enumerated from local population lists. Human papillomavirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, L K, Dai, M, Clifford, G M, Yao, W Q, Arslan, A, Li, N, Shi, J F, Snijders, P J F, Meijer, C J L M, Qiao, Y L, Franceschi, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360733/
https://www.ncbi.nlm.nih.gov/pubmed/17088908
http://dx.doi.org/10.1038/sj.bjc.6603450
_version_ 1782153121977335808
author Li, L K
Dai, M
Clifford, G M
Yao, W Q
Arslan, A
Li, N
Shi, J F
Snijders, P J F
Meijer, C J L M
Qiao, Y L
Franceschi, S
author_facet Li, L K
Dai, M
Clifford, G M
Yao, W Q
Arslan, A
Li, N
Shi, J F
Snijders, P J F
Meijer, C J L M
Qiao, Y L
Franceschi, S
author_sort Li, L K
collection PubMed
description To investigate the prevalence of, and risk factors for, cervical infection with human papillomavirus (HPV) in Shenyang City, People's Republic of China, we interviewed and obtained cervical cell samples from 685 women aged 15–59 years enumerated from local population lists. Human papillomavirus DNA was detected in cervical cell samples using a GP5+/6+-based PCR assay for 44 HPV types. Human papillomavirus prevalence was 16.8% overall and 13.6% among women without cervical abnormalities (16.6% and 12.4%, respectively, age-standardised to the world standard population), with no significant trends in HPV prevalence by age group. Of the 32 types identified, high-risk HPV types predominated in all age groups, HPV16 being the most common (3.4% of all women), followed by HPV52 (2.5%) and 58 (1.9%). Multiple-type infections accounted for 31.3% of all infected women. Not being married, reporting multiple sexual partners and husband's extramarital sexual relationships were all significantly associated with being HPV-positive. The disclosure of a relatively high HPV prevalence in Shenyang, in comparison with other worldwide populations, raises important questions concerning the prevention of cervical cancer in China, especially given the promising efficacy of prophylactic HPV vaccines.
format Text
id pubmed-2360733
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23607332009-09-10 Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study Li, L K Dai, M Clifford, G M Yao, W Q Arslan, A Li, N Shi, J F Snijders, P J F Meijer, C J L M Qiao, Y L Franceschi, S Br J Cancer Epidemiology To investigate the prevalence of, and risk factors for, cervical infection with human papillomavirus (HPV) in Shenyang City, People's Republic of China, we interviewed and obtained cervical cell samples from 685 women aged 15–59 years enumerated from local population lists. Human papillomavirus DNA was detected in cervical cell samples using a GP5+/6+-based PCR assay for 44 HPV types. Human papillomavirus prevalence was 16.8% overall and 13.6% among women without cervical abnormalities (16.6% and 12.4%, respectively, age-standardised to the world standard population), with no significant trends in HPV prevalence by age group. Of the 32 types identified, high-risk HPV types predominated in all age groups, HPV16 being the most common (3.4% of all women), followed by HPV52 (2.5%) and 58 (1.9%). Multiple-type infections accounted for 31.3% of all infected women. Not being married, reporting multiple sexual partners and husband's extramarital sexual relationships were all significantly associated with being HPV-positive. The disclosure of a relatively high HPV prevalence in Shenyang, in comparison with other worldwide populations, raises important questions concerning the prevention of cervical cancer in China, especially given the promising efficacy of prophylactic HPV vaccines. Nature Publishing Group 2006-12-04 2006-10-31 /pmc/articles/PMC2360733/ /pubmed/17088908 http://dx.doi.org/10.1038/sj.bjc.6603450 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Li, L K
Dai, M
Clifford, G M
Yao, W Q
Arslan, A
Li, N
Shi, J F
Snijders, P J F
Meijer, C J L M
Qiao, Y L
Franceschi, S
Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study
title Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study
title_full Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study
title_fullStr Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study
title_full_unstemmed Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study
title_short Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study
title_sort human papillomavirus infection in shenyang city, people's republic of china: a population-based study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360733/
https://www.ncbi.nlm.nih.gov/pubmed/17088908
http://dx.doi.org/10.1038/sj.bjc.6603450
work_keys_str_mv AT lilk humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT daim humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT cliffordgm humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT yaowq humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT arslana humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT lin humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT shijf humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT snijderspjf humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT meijercjlm humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT qiaoyl humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy
AT franceschis humanpapillomavirusinfectioninshenyangcitypeoplesrepublicofchinaapopulationbasedstudy